Ginkgo Bioworks Holdings (DNA) Tax Provisions (2020 - 2026)
Ginkgo Bioworks Holdings (DNA) posted Tax Provisions of -$80000.0 for Q1 2026, up 87.56% on a QoQ basis from -$643000.0 in Q4 2025, and down 190.91% year-over-year from $88000.0 in Q1 2025.
Ginkgo Bioworks Holdings (DNA) Tax Provisions (2020 - 2026) Analysis & Trends
Ginkgo Bioworks Holdings' Tax Provisions history runs 7 years deep, the most recent figure standing at -$80000.0 for Q1 2026.
- Quarterly Tax Provisions fell 190.91% year-over-year to -$80000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.0 million (down 138.15% YoY) and the FY2025 annual result came in at -$837000.0, down 74.74% from the prior year.
- Tax Provisions was -$80000.0 for Q1 2026 at Ginkgo Bioworks Holdings, up from -$643000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $190000.0 in Q2 2024 and bottomed at -$14.8 million in Q4 2022.
- A 5-year average of -$970235.3 and a median of -$45000.0 in 2022 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2022 — Tax Provisions slumped 2062.52% — and 2023, when it soared 248.89%.
- Ginkgo Bioworks Holdings' Tax Provisions stood at -$14.8 million in 2022, then jumped by 98.66% to -$198000.0 in 2023, then sank by 64.14% to -$325000.0 in 2024, then plunged by 97.85% to -$643000.0 in 2025, then jumped by 87.56% to -$80000.0 in 2026.
- Business Quant data shows DNA's Tax Provisions at -$80000.0 in Q1 2026, -$643000.0 in Q4 2025, and $1000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 31.86 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 179.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Ginkgo Bioworks Holdings | 517.16 Mn | 373.30 Mn | 16.38 Mn | -80,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -80,000.00 |
| Dec 31, 2025 | -643,000.00 |
| Sep 30, 2025 | 1,000.00 |
| Jun 30, 2025 | -283,000.00 |
| Mar 31, 2025 | 88,000.00 |
| Dec 31, 2024 | -325,000.00 |
| Sep 30, 2024 | -375,000.00 |
| Jun 30, 2024 | 190,000.00 |
| Mar 31, 2024 | 31,000.00 |
| Dec 31, 2023 | -198,000.00 |
| Sep 30, 2023 | -22,000.00 |
| Jun 30, 2023 | 67,000.00 |
| Mar 31, 2023 | 82,000.00 |
| Dec 31, 2022 | -14.77 Mn |
| Sep 30, 2022 | -28,000.00 |
| Jun 30, 2022 | -45,000.00 |
| Mar 31, 2022 | -184,000.00 |
| Dec 31, 2021 | -683,000.00 |
| Sep 30, 2021 | -207,000.00 |
| Jun 30, 2021 | -431,000.00 |